SCHEMBL1770152

SCHEMBL1770152

CCC(=NNC(=N)N)C(CC)=NNC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1770011 0.87
SCHEMBL7859383 0.85 HIF1A (0.34)
SCHEMBL7859385 0.85 HIF1A (0.34)
SCHEMBL7861521 0.85 HIF1A (0.34)
SCHEMBL18725187 0.80
SCHEMBL18725175 0.78
SCHEMBL11673290 0.78
SCHEMBL16275210 0.78
Hydrochloric Acid SCHEMBL9710685 0.76 PLK4 (0.31)
Hydrochloric Acid SCHEMBL9710684 0.76 PLK4 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0543949-B1 ENZYMIC ALTERATION OF HAIR GROWTH HANDELMAN JOSEPH H (US) 1997-10-22 EP claimed
EP-0543949-A4 ENZYMIC ALTERATION OF HAIR GROWTH 1993-08-04 EP claimed
EP-0543949-A1 ENZYMIC ALTERATION OF HAIR GROWTH. HANDELMAN JOSEPH H (US) 1993-06-02 EP claimed
WO-1992003140-A1 ENZYMIC ALTERATION OF HAIR GROWTH HANDELMAN JOSEPH H (US) 1992-03-05 WO claimed
EP-3831372-A1 MITOGUAZONE FOR PREVENTING THE RELAPSE OR THE PROGRESSION OF MULTIPLE SCLEROSIS Pathologica LLC (US) 2021-06-09 EP disclosed
US-20210085625-A1 CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG PATHOLOGICA LLC 2021-03-25 US disclosed
US-10881626-B2 Controlled release oral pharmaceutical dosage forms comprising MGBG PATHOLOGICA LLC (US) 2021-01-05 US disclosed
US-20190224144-A1 METHOD OF TREATMENT WITH ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS WHICH ARE GI-, RENAL-, AND PLATELET-SPARING PATHOLOGICA LLC 2019-07-25 US disclosed
US-10350178-B2 Methods and compositions for treatment of demyelinating diseases PATHOLOGICA LLC (US) 2019-07-16 US disclosed
US-10292950-B2 Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing PATHOLOGICA LLC (US) 2019-05-21 US disclosed
EP-3473247-A1 COMPOSITION FOR ORAL DELIVERY COMPRISING MGBG FOR USE IN TREATING MULTIPLE SCLEROSIS Pathologica LLC (US) 2019-04-24 EP disclosed
US-20180369170-A1 METHOD OF TREATMENT WITH ANTI-INFLAMMATORY AND ANALGESIC COMPOUNDS WHICH ARE GI-, RENAL-, AND PLATELET-SPARING PATHOLOGICA LLC 2018-12-27 US disclosed
US-20030027866-A1 Prevention of apoptosis in non-cancerous cells UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2003-02-06 US disclosed
US-6498192-B1 ADMINISTERING A POLYAMINE DEPLETING AGENT, SUCH AS DIFLUORO-METHYLORNITHINE; ORNITHINE DECARBOXYLASE INHIBITORS; PREFER-ENTIALLY KILLING CANCER CELLS VERSUS NORMAL CELLS DURING RADIATION THERAPY THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION 2002-12-24 US disclosed
WO-2002053519-A2 HYDROPHOBIC POLYAMINE ANALOGS AND METHODS FOR THEIR USE MEDIQUEST THERAPEUTICS, INC. (US) 2002-07-11 WO disclosed
EP-0543949-B1 ENZYMIC ALTERATION OF HAIR GROWTH HANDELMAN JOSEPH H (US) 1997-10-22 EP disclosed
EP-0543949-A4 ENZYMIC ALTERATION OF HAIR GROWTH 1993-08-04 EP disclosed
EP-0543949-A1 ENZYMIC ALTERATION OF HAIR GROWTH. HANDELMAN JOSEPH H (US) 1993-06-02 EP disclosed
US-5132293-A Enzyme inhibitors SHANDER DOUGLAS (US) 1992-07-21 US disclosed
WO-1992003140-A1 ENZYMIC ALTERATION OF HAIR GROWTH HANDELMAN JOSEPH H (US) 1992-03-05 WO disclosed